Judge Sets May 10 Court Hearing for Icahn’s Proxy War with Amylin

Activist shareholder Carl Icahn’s proxy war with the board of Amylin Pharmaceuticals received a boost yesterday when a Delaware judge fast-tracked a hearing on his lawsuit to replace the company’s directors. Delaware Chancery Court Judge John Noble scheduled for May 10 a hearing on delaying Amylin’s annual meeting, set to take place five days later.
Genetic Engineering & Biotechnology News